Analysts expect Domino's Pizza to report an earnings per share (EPS) of $3.94. Anticipation surrounds Domino's Pizza's announcement, with investors hoping to hear about both surpassing estimates and ...

US stocks start up on earnings reports and before a consumer sentiment survey that'll show if consumers are feeling the ...

Pfizer, in partnership with Bristol Myers Squibb, has launched a direct-to-patient sales strategy for Eliquis®, aiming to ...

Digging into the specifics of earnings season, how quarterly reports work, and how to use options players to capitalize on the events ...

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.

Pfizer faces adjusted financial forecasts as analysts lower earnings expectations for FY2025, signaling cautious optimism.

Large unusual trading volume in Pfizer, Inc. (PFE) put options that expire 30 days from now signals investors' bullish outlook on PFE stock. It trades for just over 8 times earnings, well below its 10 ...

Pfizer reaffirmed its 2025 outlook of $61 to $64 billion in revenue and adjusted earnings per share of $2.80 to $3. StockStory aims to help individual investors beat the market.

Pfizer's stock was charging 4.5% higher in recent trading, and was sharing the top spot on the S&P 500's gainers list with Fox Corp., after the drug maker provided profit and revenue guidance.

Pfizer on Tuesday reported fourth-quarter earnings and revenue that beat estimates as sales of the company's Covid products topped expectations and its broad cost-cutting efforts took hold.

Pfizer Inc. (NYSE:PFE – Free Report) – Investment analysts at Leerink Partnrs lifted their FY2025 earnings estimates for Pfizer in a report issued on Wednesday, December 18th. Leerink Partnrs ...